Evidence map›Paper›PMID 39295072›Full record

SynthesisBrain and behavior2024

Changes in the Firmicutes to Bacteriodetes ratio in the gut microbiome in individuals with anorexia nervosa following inpatient treatment: A systematic review and a case series.

Passent Helal, Wangmingyu Xia, Puspendu Sardar, Anna Conway-Morris, Andrew Conway-Morris, Virginia A Pedicord, Jaco Serfontein

Erratum issuedAbstract readSystematic Review
In one paragraph

Synthesis in Brain and behavior, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 5 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Review
  4. Review
  5. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors.

Passent HelalAdult Eating Disorders Service, Ward S3 Inpatients, Addenbrooke's Hospital, Cambridge, UK.ORCID https://orcid.org/0000-0002-7924-3050
Wangmingyu XiaDepartment of Medicine, Cambridge Institute of Therapeutic Immunology & Infectious Disease, University of Cambridge, Cambridge, UK.
Puspendu SardarDepartment of Medicine, Cambridge Institute of Therapeutic Immunology & Infectious Disease, University of Cambridge, Cambridge, UK.
Anna Conway-MorrisAdult Eating Disorder Service, Ward S3 Outpatients, Addenbrooke's Hospital, Cambridge, UK.
Andrew Conway-MorrisDivision of Anaesthesia, Department of Medicine, University of Cambridge, Cambridge, UK.
Virginia A PedicordDepartment of Medicine, Cambridge Institute of Therapeutic Immunology & Infectious Disease, University of Cambridge, Cambridge, UK.
Jaco SerfonteinAdult Eating Disorders Service, Ward S3 Inpatients, Addenbrooke's Hospital, Cambridge, UK.

Funding

Medical Research Council MR/V006118/1Royal College of PsychiatristsWellcome TrustWellcome Trust and the Royal Society 206245/Z/17/Z
6 · The paper itself

Abstract

objectiveAnorexia nervosa has the highest mortality rate among psychiatric illnesses. Current treatments remain ineffective for a large fraction of patients. This may be due to unclear mechanisms behind its development and maintenance. Studies exploring the role of the gut microbiome have revealed inconsistent evidence of dysbiosis. This article aims to investigate changes in the gut microbiome, particularly, mean differences in the Firmicutes to Bacteroidetes ratio, in adolescent and adult individuals with anorexia nervosa following inpatient treatment.

methodsLongitudinal studies investigating gut microbiome composition in inpatient populations of anorexia nervosa before and after treatment were systematically reviewed. Additionally, gut microbiome compositions were characterized in three acute anorexia nervosa inpatients early after admission and after 4-12 weeks of treatment.

resultsReview results indicated an increase in the Firmicutes to Bacteroidetes ratio in individuals with anorexia nervosa after treatment. These however did not match values of their healthy counterparts. In the case-series samples, the reverse occurred with samples taken 4 weeks after treatment. In the patient who provided an extra sample 12 weeks after treatment, similar results to the studies included in the review were observed. Furthermore, Firmicutes to Bacteroidetes ratio values in the case-series samples were notably higher in the two patients who had chronic anorexia nervosa. DISCUSSION: Differences in methodologies, small sample sizes, and insufficient data limited the generalizability of the outcomes of the reviewed studies. Results suggest a potentially unique microbiome signature in individuals with chronic anorexia nervosa, which may explain different outcomes in this group of patients.

Indexed as

Anorexia NervosaBacillotaBacteroidetesGastrointestinal MicrobiomeInpatientsAdolescentAdultDysbiosisFemaleHumansYoung Adultanorexia nervosainpatient treatmentmicrobiome

Identifiers

PMID39295072
PMCPMC11410858

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.